Methods We searched PubMed, Embase, Cochrane and ClinicalTrials.gov up until 27 October 2021 for randomised controlled trials with a duration of at least 12 weeks that compared once-weekly tirzepatide 5, 10 or 15 mg with placebo or other glucose-lowering drugs in adults with type 2 diabetes irrespective of their background glucose-lowering treatment
There are no easy answers for people who cannot afford a GLP-1 drug but remain desperate to lose weight or maintain their weight loss
Your healthcare provider will confirm the appropriate frequency based on your diagnosis, comorbidities, renal function, and tolerability profile
The innovations in drug design and formulation that we just covered, including dual and triple agonists or conjugates with other hormonal pathways, are helping driving this expansion by delivering greater weight loss and metabolic benefits while reducing side effects through synergistic mechanisms
Natural GLP-1 breaks down within minutes
You can rest easy knowing that we will be here to provide the support and encouragement you need every step of the way